These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 853464)

  • 1. The law in relation to unforeseen adverse drug reactions.
    Wilmers J
    J R Coll Physicians Lond; 1977 Apr; 11(3):247-54. PubMed ID: 853464
    [No Abstract]   [Full Text] [Related]  

  • 2. Unwanted drug effects: whose responsibility?
    Lancet; 1979 Jul; 2(8132):21. PubMed ID: 87894
    [No Abstract]   [Full Text] [Related]  

  • 3. Opren deaths kept secret, admits Lilly.
    Joyce C; Lesser F
    New Sci; 1985 Aug; 107(1471):15-6. PubMed ID: 11655708
    [No Abstract]   [Full Text] [Related]  

  • 4. The marketing of a drug.
    Wolfe SM
    Health Med; 1982; 1(2):31-2. PubMed ID: 10257087
    [No Abstract]   [Full Text] [Related]  

  • 5. MEDICO-LEGAL ASPECTS OF DRUG TOXICITY.
    CONSTABLE HA
    Practitioner; 1965 Jan; 194():22-5. PubMed ID: 14259686
    [No Abstract]   [Full Text] [Related]  

  • 6. Adverse drug reactions.
    Lawson DH
    Hum Toxicol; 1985 Mar; 4(2):122-6. PubMed ID: 4007876
    [No Abstract]   [Full Text] [Related]  

  • 7. Communicating adverse drug reactions.
    Lancet; 1978 Jan; 1(8056):133. PubMed ID: 87560
    [No Abstract]   [Full Text] [Related]  

  • 8. Compensation for drug injury. Problems both sides of the Atlantic.
    Smith R
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1443-5. PubMed ID: 6784859
    [No Abstract]   [Full Text] [Related]  

  • 9. Compensating the drug victim.
    Lancet; 1978 Jul; 2(8079):26. PubMed ID: 78220
    [No Abstract]   [Full Text] [Related]  

  • 10. Monitoring adverse reactions to drugs.
    Dollery CT; Rawlins MD
    Br Med J; 1977 Jan; 1(6053):96-7. PubMed ID: 832028
    [No Abstract]   [Full Text] [Related]  

  • 11. Are drug companies a little too vigorous?
    Radcliffe M
    Nurs Times; 2004 Jul 13-19; 100(28):156. PubMed ID: 15311541
    [No Abstract]   [Full Text] [Related]  

  • 12. Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
    Cahal DA
    Can Med Assoc J; 1968 Feb; 98(6):271-5. PubMed ID: 5636096
    [No Abstract]   [Full Text] [Related]  

  • 13. Crying wolf on drug safety.
    Br Med J (Clin Res Ed); 1982 Jan; 284(6311):219-20. PubMed ID: 6799107
    [No Abstract]   [Full Text] [Related]  

  • 14. Secret out-of-court settlements in drug-injury cases.
    Herxheimer A
    Lancet; 1999 Feb; 353(9152):517-8. PubMed ID: 10028977
    [No Abstract]   [Full Text] [Related]  

  • 15. New strategies for drug monitoring.
    Br Med J; 1977 Apr; 1(6065):861-2. PubMed ID: 851762
    [No Abstract]   [Full Text] [Related]  

  • 16. A regulatory view of the Medicines Act in the United Kingdom.
    Andrews PA; Thompson GM; Ward C
    J Clin Pharmacol; 1984 Jan; 24(1):6-18. PubMed ID: 6368615
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: The drug makers.
    Med J Aust; 1974 Oct; 2(16):583-4. PubMed ID: 4437418
    [No Abstract]   [Full Text] [Related]  

  • 18. Drugs monitor needs sharper teeth.
    Lesser F
    New Sci; 1983 Mar; 97(1349):729-32. PubMed ID: 11655525
    [No Abstract]   [Full Text] [Related]  

  • 19. Living organisms in patent law.
    Hill MM
    Lancet; 1970 Nov; 2(7680):986-7. PubMed ID: 4097635
    [No Abstract]   [Full Text] [Related]  

  • 20. Control and distribution of medicines in the future.
    Cook AM
    R Soc Health J; 1971; 91(5):222-4. PubMed ID: 5154143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.